| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 2 Jan 25 | VKTX Viking Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 41.12 | 18,800 | 773.06 k | 18,800 |
| 8 Nov 24 | VKTX Viking Therapeutics | Common Stock, par value $0.00001 per share | Sell | Dispose S | No | No | 68.6667 | 2,000 | 137.33 k | 47,965 |
| 8 Nov 24 | VKTX Viking Therapeutics | Common Stock, par value $0.00001 per share | Option exercise | Acquire M | No | No | 5.8 | 2,000 | 11.60 k | 49,965 |
| 8 Nov 24 | VKTX Viking Therapeutics | Stock Option Common Stock | Option exercise | Dispose M | No | No | 5.8 | 2,000 | 11.60 k | 20,000 |
| 2 Jan 24 | VKTX Viking Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 18.28 | 32,000 | 584.96 k | 32,000 |
